← Back to Search

Peer Support + HIT for High Blood Pressure (PT4A Trial)

N/A
Waitlist Available
Led By Rajesh Vedanthan, MD, MPH
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult patients ≥ 18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 12
Awards & highlights

PT4A Trial Summary

This trialwill test a new intervention to improve medication adherence for hypertension control, aiming to reduce blood pressure. It will assess feasibility, adherence & implementation fidelity, and compare blood pressure between trial & control groups.

Who is the study for?
This trial is for adults over 18 with high blood pressure that isn't well-controlled (systolic ≥ 140 or diastolic ≥ 90) and are enrolled in the AMPATH CDM Program. It's not for those with acute illnesses needing immediate attention, terminal illness, or who can't consent.Check my eligibility
What is being tested?
The study tests if peer delivery of medications combined with a Health Information Technology platform improves medication adherence and blood pressure control in western Kenya. It includes pilot intervention, surveys, and compares results to a matched control group.See study design
What are the potential side effects?
Since this trial focuses on delivering existing hypertension medications through peers and technology rather than testing new drugs, it does not introduce additional side effects beyond those already associated with the participants' current hypertension treatments.

PT4A Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

PT4A Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Absolute Mean Change in Systolic Blood Pressure (SBP)
Number of Confirmed Medication Deliveries
Number of Peer Completions of HIT Form
+1 more

PT4A Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients Enrolled in the AMPATH CDM ProgramExperimental Treatment2 Interventions

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,358 Previous Clinical Trials
816,713 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,814 Previous Clinical Trials
47,290,775 Total Patients Enrolled
Rajesh Vedanthan, MD, MPHPrincipal InvestigatorNYU Langone Health
2 Previous Clinical Trials
3,490 Total Patients Enrolled

Media Library

Health Information Technology (HIT) Platform Clinical Trial Eligibility Overview. Trial Name: NCT05051124 — N/A
High Blood Pressure Research Study Groups: Patients Enrolled in the AMPATH CDM Program
High Blood Pressure Clinical Trial 2023: Health Information Technology (HIT) Platform Highlights & Side Effects. Trial Name: NCT05051124 — N/A
Health Information Technology (HIT) Platform 2023 Treatment Timeline for Medical Study. Trial Name: NCT05051124 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~34 spots leftby Mar 2025